- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2006
- Public Summary Document (PSD) March 2006 PBAC Meeting - PDF
Infliximab – March 2006
Infliximab, powder for intravenous infusion, 100 mg, Remicade® , March 2006
Last updated
30 June 2006